HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Incidental mesangial IgA deposition in minimal change nephrotic syndrome(MCNS)].

Abstract
The frequency of incidental mesangial IgA deposition and its clinicopathological features were investigated in patients with minimal change nephrotic syndrome(MCNS). Mesangial IgA deposition was present in 15/63 patients(23.8%), and co-deposition of IgA and C3 was present in 10/63 patients(15.9%). The serum IgA concentration was significantly higher in IgA(+) patients than in IgA(-) patients(341 +/- 79 mg/dl vs. 252 +/- 99 mg/dl, p = 0.034). The urinary red blood cell count tended to be higher in IgA(+) patients than in IgA(-) patients (12.8 +/- 24.9 vs. 5.0 +/- 7.9 counts/HPF, p = 0.58). Histologically, no significant differences were observed between IgA(+) and IgA(-) patients. After steroid treatment. 14 patients with mesangial IgA deposition showed complete remission and one patient had persistent proteinuria. The microhematuria also disappeared after steroid treatment in 13/15 patients (86.7%), although it reappeared in 6/13 patients(46%) during reduction of steroid administration. The present study indicated that the incidental mesangial IgA deposition was frequently observed in MCNS patients(23.8%). The phenomenon of mesangial IgA deposition was related to the higher concentration of serum IgA. However, no influence of mesangial IgA deposition in MCNS patients was found on the post-treatment amount of proteinuria, renal function and clinical outcome of MCNS.
AuthorsMisao Tsukada, Kazuho Honda, Kosaku Nitta, Wako Yumura, Hiroshi Nihei
JournalNihon Jinzo Gakkai shi (Nihon Jinzo Gakkai Shi) Vol. 45 Issue 7 Pg. 681-8 (Oct 2003) ISSN: 0385-2385 [Print] Japan
PMID14631763 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Immunoglobulin A
Topics
  • Adult
  • Female
  • Glomerular Mesangium (immunology, ultrastructure)
  • Glomerulonephritis, IGA (etiology, pathology)
  • Humans
  • Immunoglobulin A (metabolism)
  • Male
  • Nephrosis, Lipoid (complications, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: